New Edge Advisors, LLC Sab Biotherapeutics Inc Wt Exp Transaction History
New Edge Advisors, LLC
- $15 Billion
- Q3 2024
A detailed history of New Edge Advisors, LLC transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,072 shares of SABSW stock, worth $117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,072
Previous 1,072
-0.0%
Holding current value
$117
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SABSW
# of Institutions
12Shares Held
361KCall Options Held
602KPut Options Held
0-
Morgan Stanley New York, NY146KShares$16,1080.0% of portfolio
-
Yakira Capital Management, Inc. Westport, CT108KShares$11,9330.0% of portfolio
-
Hb Wealth Management, LLC50KShares$5,5000.0% of portfolio
-
Walleye Capital LLC Plymouth, MN23.3KShares$2,5580.0% of portfolio
-
Wolverine Asset Management LLC15.5KShares$1,7070.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology